Acute Hepatic Insufficiency with Portal Vein Thrombosis Management

Initial Diagnostic Workup

The American Association for the Study of Liver Diseases recommends performing comprehensive laboratory testing, including complete blood count, comprehensive metabolic panel, coagulation studies, serum acetaminophen levels, viral hepatitis serologies, and toxicology screen in urine, for patients with acute hepatic insufficiency and portal vein thrombosis 3
Doppler ultrasound of the liver is recommended as the first-line investigation to assess portal vein patency and extent of thrombosis, according to the European Association for the Study of the Liver 1, 3
CT scan is recommended for diagnostic confirmation and assessment of thrombus extension, as suggested by the American College of Gastroenterology 1
Echocardiography is recommended to exclude cardiac causes and assess hemodynamic status, as recommended by the American Heart Association 3

The American College of Gastroenterology recommends assessing the extent and severity of thrombosis, including determining if thrombosis is partial or complete, and identifying which vessels are involved 2, 5
The European Association for the Study of the Liver recommends evaluating for signs of intestinal ischemia, including abdominal pain, elevated lactate, and mesenteric fat stranding on imaging 2

The American College of Chest Physicians recommends initiating immediate anticoagulation with low-molecular-weight heparin in patients with acute hepatic insufficiency and portal vein thrombosis, with a target anti-Xa activity between 0.5-0.8 IU/ml 1, 2
The International Society on Thrombosis and Haemostasis recommends considering transition to oral anticoagulants for long-term management, including vitamin K antagonists and direct oral anticoagulants 1, 2, 5

The American Association for the Study of Liver Diseases recommends screening for gastroesophageal varices in all patients with portal vein thrombosis, and managing portal hypertensive bleeding with early endoscopy, octreotide or somatostatin analogs, and proton pump inhibitors 1, 2, 6

The Society of Critical Care Medicine recommends maintaining hemoglobin >7 g/dL during resuscitation, and mean arterial pressure >65 mmHg while avoiding fluid overload, in patients with acute hepatic insufficiency 7
The American Association for the Study of Liver Diseases recommends correcting coagulopathy, monitoring for and treating hepatic encephalopathy, and avoiding nephrotoxic drugs, including NSAIDs 3, 7

The Infectious Diseases Society of America recommends providing prolonged antibiotic treatment adapted to isolated bacteria or anaerobic digestive flora when septic pylephlebitis is diagnosed, and initiating empiric broad-spectrum antibiotics in patients with signs of systemic inflammatory response syndrome 1, 4

The American College of Gastroenterology recommends managing patients with intestinal ischemia with a multidisciplinary team, and considering interventional approaches, including thrombectomy and thrombolysis, if no clinical improvement with anticoagulation 2
The American Society of Transplantation recommends continuing anticoagulation until transplantation, and considering portal vein revascularization with TIPS to improve candidacy for transplantation, in liver transplant candidates 5